IP Verse

Taiho Pharmaceutical patent opposition analysis

Get complete Patent Opposition Report for Taiho Pharmaceutical

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Taiho Pharmaceutical opposed by its competitors

Explore Taiho Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP1849470	Mar 20, 2024	Anticancer Drug Containing Alpha, Alpha, Alphatrifluorothymidine And Thymidine Phosphorylase Inhibitor	4
EP3042669	Mar 8, 2023	Antitumor Agent And Antitumor Effect Enhancer	2
EP3012255	Oct 13, 2021	Stabilized Crystal Of Tipiracil Hydrochloride, And Crystallization Method For Same	1
EP2815752	May 20, 2020	Oral Pharmaceutical Composition	1
EP2815753	May 16, 2018	Oral Pharmaceutical Composition	1

Top competitors of Taiho Pharmaceutical

GENERICS UK

STADA ARZNEIMITTEL

TEVA PHARMACEUTICAL INDUSTRIES